DREAM3R – New Mesothelioma Trial opens at Flinders Medical Centre

Research into the treatment of mesothelioma is ongoing, although progress has been slow. The latest research (DREAM3R) will be trialed at hospitals around Australia.It uses an immunotherapy drug (Durvalumab) in conjunction with the standard chemotherapy treatment. The hope is that the treatment will lead to an increased survival rate (longer life expectancy – it is …
Continue reading DREAM3R – New Mesothelioma Trial opens at Flinders Medical Centre